MARK F. MCCARTY. Flavones and Flavonols may have Clinical Potential as CK2 Inhibitors in Cancer Therapy. Cancer Studies and Molecular Medicine , [S. l.], v. 2, n. 1, p. 39–51, 2015. DOI: 10.17140/CSMMOJ-2-105. Disponível em: https://openventio.us/index.php/CSMM/article/view/1403. Acesso em: 14 nov. 2026.